Background: Dexmedetomidine is a potent non-opioid analgesic that may enhance analgesia for cataract surgery under topical anaesthesia. This study was undertaken to assess sedation and analgesia provided by dexmedetomidine and evaluating patients'
Introduction
Traditionally, cataract surgeries are performed under regional anaesthesia with either a peribulbar or retrobulbar block. With the anaesthesia has also evolved from painful regional blocks to painless topical anaesthesia. 1 However, with topical anaesthesia the patient has to cooperate for an akinetic eye as compared with a regional block. The requirement for cooperation may lead to increased anxiety in patients. Moreover, the fall in intraocular pressure (IOP) seen with regional block, which is desirable for a good operative is preferred as the patient is not required to undergo the painful injections for blocks and avoids the complications of blocks, including globe perforation and optic nerve injury. 1, 2 Nevertheless, all cataract surgeries whether under regional blocks or topical anesthesia are performed under monitored anesthesia care (MAC) requiring the presence of an anaesthetist. 3 Several agents such as propofol, midazolam and opioids have been used to allay anxiety and provide sedation for cataract surgery. [4] [5] [6] However, each of these drugs has limitations including over-sedation leading to impairment of patient's cooperation and respiratory depression. Dexmedetomidine is an alpha2 agonist that provides sedation and analgesia without respiratory depression. 7, 8 Dexmedetomidine, through its central action, has been shown to decrease IOP. 9 Previous studies on dexmedetomidine have been conducted either in cataract surgeries under regional blocks or have not included IOP in the studied parameter. 10, 11 The aim of our study on patient's satisfaction by assessing sedation and pain scores as well as surgeon's satisfaction by assessing the operating under topical anaesthesia.
Material and methods
After institutional ethics committee approval, the study was conducted on 60 patients as a placebo controlled, randomized double blind study. Patients were fully informed about the study protocol and provided written informed consent.
cataract surgery under topical anaesthesia. Exclusion criteria were any contraindication to the use of dexmedetomidine (cardiac disorders, hypertensive patients on beta blockers, liver and kidney diseases). Using a computer generated randomisation schedule, patients were assigned to either of the following two groups:
• Group D: Received dexmedetomidine premedication (n = 30)
• Group C: Received saline (n During the preanaesthesia check-up, numeric rating scale (NRS) 3 On arrival in the operating theatre, basic monitors were attached and the baseline values of heart rate (HR), mean arterial pressure (MAP), respiratory rate (RR), oxygen saturation (spO 2 ), end tidal carbon dioxide using a side stream port (etCO 2 ) and electrocardiogram (ECG) were recorded.
The page number in the footer is not for bibliographic referencing www.tandfonline.com/ojaa 18 Group D received intravenous infusion of dexmedetomidine the same rate. The infusion was started by anesthesiologist who was delivered to all patients using a nasal cannula. Intraoperative sedation was monitored using Ramsay sedation score (RSS) 12 target end point was reached before completing the infusion, the infusion was stopped and noted. All the parameters to be studied i.e. HR, MAP, spO 2 , RR, etCO 2 , NRS (pain and patient satisfaction) and RSS were monitored and recorded for each patient before premedication (T1), after premedication (T2), intra operatively (T3) and post operatively (T4). The ophthalmologist, blinded to the study group, measured the IOP using a Schioetz tonometer under topical analgesia in the non-operated eye. The IOP was recorded before the premedication and at the end of the surgery. Surgery was performed under topical anaesthesia using instillation of few drops of 0.5% paracaine.
values below 20% of baseline) was recorded and treated with intravenous atropine or ephedrine respectively. All adverse events including but not limited to respiratory depression, nausea, vomiting, dry mouth and oversedation were also noted. fentanyl 1 mcg/kg. The number of patients who needed fentanyl was recorded.
At the end of surgery, patients were asked about average level of pain and the surgeon satisfaction was assessed by the adequacy of operating conditions using the following scale: excellent (completely calm and cooperative patient), good (cooperative patient but slight undesirable movements of eyes) and poor (highly uncooperative patient with severe undesirable movements of eyes). 3 Patients were monitored in the recovery room, their Aldrete score observed and then discharged to the ward. All the study data was recorded by a blinded observer.
Based upon previously published data, 10, 11 we assumed that the whereas with dexmedetomidine, sedation would be obvious in at least 40% of patients and this provided an 80% power with an error equal to 0.05, therefore a sample size of 22 patients per cases with violation of study protocol, a total of 30 cases were studied in each group. 
Results
The groups were comparable in terms of demographic data, ASA grading and duration of surgery ( Table 1) .
The mean dexmedetomidine dose in group D was 65.4(3.6) mcg (1.08 mcg/kg)
The baseline values of HR and MAP were similar in both study groups. However, a gradual fall in both HR and MAP was recorded in group D after completion of infusion which continued throughout the intra and postoperative period (p). One patient in group D needed atropine for bradycardia, but the study drug was not stopped after atropine administration. There was a fall in MAP, but none of the patients needed ephedrine treatment. (Table 2 ) The etCO 2 monitored from the side stream capnometer, albeit a rough indication of ventilation, was maintained in both the groups (Figure 1 ). Despite an apparently normal etCO 2 on monitor, any occurrence of hypoventilation could not be precisely ruled out.
All patients received oxygen by nasal prongs, the saturation was maintained and respiratory rate was never below 10/min in both the groups (Figures 2 and 3 ).
The preoperative IOP values were similar in both the groups.
postoperatively as compared to group C (from mean 3)
While comparing the sedation, we observed that the overall RSS was higher at all times after completion of premedication in group D (p 3, the patients had a lower RSS in group C.
The patients' NRS for studying overall satisfaction was higher in improvement in patient's satisfaction with dexmedetomidine premedication. In group D, a maximum score of 10 was given by patients, while in group C, the maximum score given was 8 (Table 3) .
Neither the intraoperative (p (p 3). However two patients in group C demanded rescue analgesia and were given fentanyl boluses. None of the patients in group D
3)
In group D, the quality of operating conditions as assessed by ophthalmologist (surgeon satisfaction score) was rated excellent in 26 patients and good in rest 4, while in group C, only 13 patients had excellent conditions and other 17 had good operating conditions. None of the patients exhibited poor operating conditions. This p 3)
with none in group C (p The page number in the footer is not for bibliographic referencing www.tandfonline.com/ojaa 20 aminobutyric system, 7 contrary to the situation with the benzodiazepines. 18, 19 studies. 10, 11, 18 Patients were more comfortable with better sedation scores in group D. This could be explained, at least in part, by the additional analgesic property of dexmedetomidine that improves patient's perception of sedation. 8, 15 However, we could not demonstrate better pain scores in group D, as topical anesthesia itself provided adequate sensory anaesthesia.
Dexmedetomidine, by its central action leads to a fall in IOP. 7, 20 sedated but cooperative patient would provide better operating conditions providing a reason for better surgeon satisfaction in group D. The reduced IOP found in this study is in agreement with the study results of Ayoglu et al. 11 The single dose of dexmedetomidine, used in this study is not occurrence of dry mouth is an established fact with the use of alpha 2 agonists 7 but did not reduce patient satisfaction.
There are limitations to this study. Firstly, only ASA status I and II status III/IV, further studies recruiting high-risk patients need to be carried out. A second limitation was in monitoring respirationalthough saturation and respiratory rate were accurately monitored, we used a side stream capnometer to monitor etCO 2 , which requires airway instrumentation for accurate measurement and is inherently less accurate in sedated patients without airway capnometer has been used previously to measure etCO 2 in sedated patients. 10 Another possible limitation is the use of RSS to monitor sedation as opposed to the use of bispectral index or entropy. The RSS is more appropriate for sedated patients while monitoring depth of anaesthesia is more appropriate for general anaesthesia and monitors may not be readily available in all institutions.
Conclusion
We conclude that dexmedetomidine can be used safely for MAC in cataract surgery as the drug is associated with better patient and surgeon satisfaction. However, patients need to be closely monitored, following minimum monitoring standards.
Other adverse events like nausea, vomiting or over sedation were not recorded in either groups.
Both the groups achieved Aldrete scores of 10 by the end of 30th
Discussion
We conducted this randomised double-blind study in an attempt patient's and surgeon's satisfaction in patients undergoing
We observed that dexmedetomidine provides conscious sedation with better patient cooperation and satisfaction, decreases the IOP leading to improved operating conditions and better surgeon satisfaction.
anaesthesia is the preferred method for lens replacement. 1, 2 However, motor activity remains spared in topical anaesthesia and hence akinesis of eye is not achieved, causing discomfort to both the patient and surgeon. 1 responsible for sedation and anxiolysis produced by dexmedetomidine. 7 Patients premedicated with dexmedetomidine typically stay tranquil and cooperative while sleeping when unstimulated. [13] [14] [15] This characteristic of dexmedetomidine has prompted its use in patients undergoing day case surgery without 14 On the other hand, use of propofol and opioids more commonly leads to over-sedation and respiratory depression and may also delay the recovery of patients when used for a day case operations like cataract surgery. 4, 16 Alhashemi et al. compared midazolam with dexmedetomidine sedation for cataract surgery under topical anesthesia and found dexmedetomidine was inferior to midazolam due to a higher incidence of cardiovascular depression and delayed recovery. 10 These results are in contradiction with our study results. This may be explained by the fact that in the study by Alhashemi et al., the loading dose of dexmedetomidine was followed by a maintenance infusion, which was not done in our study using a loading dose alone. Dexmedetomidine when given as a loading dose has an 8,9 11 The quality rescue sedation is reduced as compared to midazolam with no 14, 15 The HR and MAP were found to be low with premedication in our study. This is attributed to the central sympatholysis after dexmedetomidine administration. 7, 8, 17 Similar results have been obtained in previous studies. 10, 18 None of the patients developed bradypnoea in our study. Dexmedetomidine is unique in that it does not cause respiratory
